HighLight Capital Terms and Conditions
  • Home
  • About
  • Team
  • Portfolio
  • News
  • Contact Us
HighLight Capital Terms and Conditions

Latest News

Pharmaron Announced 117 Million H-Shares on the Hong Kong Stock Exchange
2019-11-28

Pharmaron Announced 117 Million H-Shares on the Hong Kong Stock Exchange

Pharmaron announced today that 117 million H-shares are listed on the Main Board of The Stock Exchange of Hong Kong
Pharmaron Announces Listing of Initial Public Offering on Shenzhen Stock Exchange
2019-01-28

Pharmaron Announces Listing of Initial Public Offering on Shenzhen Stock Exchange

Pharmaron announced today its initial public offering (IPO) on the Shenzhen Stock Exchange(Stock Code: 300759.SZ)
Allergan to Acquire Bonti Adding New Neurotoxin Programs to Medical Aesthetics Pipeline
2018-09-14

Allergan to Acquire Bonti Adding New Neurotoxin Programs to Medical Aesthetics Pipeline

Acquisition Adds Fast-Acting Neurotoxin Programs with 2 to 4-Week Duration to Allergan's Best-in-Class Medical Aesthetics Portfolio and Pipeline
  • 1
  • 2
  • 3
  • 4
  • 5
  • 27 records in total
HighLight Capital Terms and Conditions
Home
About
Team
Portfolio
News
Contact Us
Copyright © 2014-2025 HighLight Capital Terms and Conditions. All Rights Reserved.